Updating protections for human subjects involved in research

JAMA

Volumn 280, Issue 22, 1998, Pages 1951-1958

  Moreno, Jonathan ^a   Caplan, Arthur L ^a   Wolpe, Paul Root ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COGNITIVE DEFECT; ETHICS; FINANCE; HUMAN EXPERIMENT; HUMAN RIGHTS; INFORMED CONSENT; MEDICAL RESEARCH; MINORITY GROUP; PRIORITY JOURNAL; REVIEW; WELFARE;

EID: 0032501363     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.22.1951     Document Type: Review

References (36)

1. Faden RR, Beauchamp TL, King NMP. A History and Theory of Informed Consent. New York, NY: Oxford University Press; 1986.
2. Levine RJ. Ethics and Regulation of Clinical Research. 2nd ed. New Haven, Conn: Yale University Press; 1986.
3. Federal policy for the protection of human subjects; notices and rules. 56 Federal Register 28002-28032, June 18, 1991.
4. Inspector General, Department of Health and Human Services. Institutional Review Boards: A System in Jeopardy? Washington, DC: US Dept of Health and Human Services; June 1998. Publication OCI-01-97-00190.
5. House Government Reform and Oversight Committee, US House of Representatives. Hearings: Clinical Trials and Patient Safety. Washington, DC: US House of Representatives; April 22, 1998.
6. US General Accounting Office. Scientific Research: Continued Vigilance Critical to Protecting Human Subjects. Washington, DC: US General Accounting Office; March 1996. Publication GAO/HEHS-96-72.
7. Gambia Government/Medical Research Council Joint Ethical Committee. Ethical issues facing medical research in developing countries. Lancet. 1998; 351:286-287.
8. Appelbaum P. Drug free research in schizophrenia: an overview of the controversy. IRB. 1996;18:1-5.
9. Hilts PJ. Experiments on children are reviewed. New York Times. April 15, 1998:B3.
10. Jos PH, Marshall MF. The Charleston policy on cocaine use during pregnancy: a cautionary tale. J Law Med Ethics. 1995;23:120-128.
11. Robertson JA. The case of the switched embryos. Hastings Cent Rep. 1995; 25:13-19.
12. US Food and Drug Administration. Protection of human subjects: informed consent and waiver of informed consent requirements in certain emergency research; final rules. 61 Federal Register 51497-51531, October 2, 1996.
13. Backlar P. Assessing decision making capacity: a slippery business. Community Mental Health J. 1996;32:321-325.
14. Hewlett S. Consent to clinical research: adequately voluntary or substantially influenced? J Med Ethics. 1996;22:232-237.
15. Kruzewski MG. Reconceiving the family: the process of consent in medical decisionmaking. Hastings Cent Rep. 1996;26:30-37.
16. Levine C. Changing views of justice after belmont: ads and the inclusion of "vulnerable" subjects. In: Vanderpool HY, ed. The Ethics of Research Involving Human Subjects. Frederick, Md: University Publishing Group; 1996:105-126.
17. Levine C, Dubler NN, Levine RJ. Building a new consensus: ethical principles and policies for clinical research on HIV/AIDS. IRB. 1996;13:1-12.
18. Merton V. Impact of current federal regulations on the inclusion of female subjects in clinical trials. In: Mastroianni AC, Faden R, Federman D, eds. Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies. Washington, DC: National Academy Press; 1994.
19. Moreno JD. Ethical considerations of industry-sponsored research: the use of human subjects. J Am Coll Nutr. 1996;15:35S-40S.
20. Rodwin MA. Money, Medicine, and Morals. New York, NY: Oxford University Press; 1993.
21. Spece RT, Shimm DS, Buchanan AE, eds. Conflicts of Interest in Clinical Practice and Research. New York, NY: Oxford University Press; 1986.
22. Advisory Committee on Human Radiation Experiments. The Human Radiation Experiments. New York, NY: Oxford University Press; 1996.
23. Brock DW. Ethical issues in exposing children to risks in research. In: Grodin MA, Glantz L, eds. Children as Research Subjects. New York, NY: Oxford University Press; 1996:81-102.
24. TD v NY State Office of Mental Health, AD2D, 650 NYS2D 173 (1st Dep't 1996).
25. Karlawish JHT, Sachs GS. Research upon the cognitively impaired: lessons and warnings from the emergency research controversy. J Am Geriatr Soc. 1997;45:474-481.
26. Jones J. Bad Blood: The Tuskegee Syphilis Experiment. New York, NY: Free Press; 1981:26.
27. Caplan AL. Am I My Brother's Keeper? Bloomington: Indiana University Press; 1998.
28. Daugherty C, Ratain MJ, Grochowski E, et al. Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol. 1995;13:1062-1072.
29. Schaeffer MH, Krantz DS, Wichman A, Masur H, Reed E, Vinicky JK. The impact of disease severity on the informed consent process in clinical research. Am J Med. 1996;100:261-268.
30. Appelbaum PS, Roth LH, Lidz CW, Benson P, Winslade W. False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep. 1987;17:20-25.
31. Ivy EJ, Lorenc ZP, Aston SJ. Is there a difference? a prospective study comparing lateral and standard SMS face lifts with extended SMAS and composite rhytidectomies. Plast Reconstr Surg. 1996;98:1135-1143.
32. Gordon VM, Sugarman J, Kass N. Toward a more comprehensive approach to protecting human subjects: the interface of data safety monitoring boards and institutional review boards in randomized clinical trials. IRB. 1998;20:1-5.
33. Gray B, Cooke B, Tannenbaum A. Research involving human subjects. Science. 1978;201:1094-1101.
34. Kodish E, Whitehouse P, Murray T. Conflict of interest in university-industry research relationships: realities, politics and values. Acad Med. 1996;71: 1287-1290.
35. Blumenthal D. Ethics issues in academic-industry relationships in the life sciences: the continuing debate. Acad Med. 1996;71:1291-1296.
36. Institute of Medicine. Review of the Fialuridine (FIAU) Clinical Trials. Washington, DC: National Academy Press; 1995.